Skip to main content
Top
Published in: neurogenetics 4/2010

01-10-2010 | ORIGINAL ARTICLE

Age at onset in Huntington’s disease: replication study on the associations of ADORA2A, HAP1 and OGG1

Authors: Elahe Taherzadeh-Fard, Carsten Saft, Stefan Wieczorek, Jörg T. Epplen, Larissa Arning

Published in: Neurogenetics | Issue 4/2010

Login to get access

Abstract

In previous candidate gene studies, associations of the age at onset (AO) in Huntington disease (HD) have been reported with genetic variations in the genes encoding adenosinergic A2A receptor (ADORA2A), human huntingtin-associated protein-1 (HAP1) and the single base excision repair enzyme, 7,8-dihydro-8-oxoguanine-DNA glycosylase (OGG1). Here, we sought to replicate these associations in an established study population of 419 unrelated German HD patients. AO was defined as the age at which the first motor signs of HD appeared, motor AO (mAO). For 215 patients, also information about the first behavioural or cognitive signs of HD was available, so that we also tested for an association with the earliest AO. No association was found with OGG1. For HAP1, we found modest evidence for association with the same risk allele as in the original sample and mAO. Yet, we replicated the previously reported association between the original ADORA2A polymorphism when using the earliest AO. Additionally, we identified new associations in the same gene, thus further supporting the potential contribution of ADORA2A to the pathogenesis of HD.
Literature
1.
go back to reference Gusella JF, Macdonald ME (2009) Huntington's disease: the case for genetic modifiers. Genome Med 1:80CrossRefPubMed Gusella JF, Macdonald ME (2009) Huntington's disease: the case for genetic modifiers. Genome Med 1:80CrossRefPubMed
2.
go back to reference Arning L, Kraus PH, Valentin S, Saft C, Andrich J, Epplen JT (2005) NR2A and NR2B receptor gene variations modify age at onset in Huntington disease. Neurogenetics 6:25–28CrossRefPubMed Arning L, Kraus PH, Valentin S, Saft C, Andrich J, Epplen JT (2005) NR2A and NR2B receptor gene variations modify age at onset in Huntington disease. Neurogenetics 6:25–28CrossRefPubMed
3.
go back to reference Andresen JM, Gayán J, Cherny SS, Brocklebank D, Alkorta-Aranburu G, Addis EA, US-Venezuela Collaborative Research Group, Cardon LR, Housman DE, Wexler NS (2007) Replication of twelve association studies for Huntington's disease residual age of onset in large Venezuelan kindreds. J Med Genet 44:44–50CrossRefPubMed Andresen JM, Gayán J, Cherny SS, Brocklebank D, Alkorta-Aranburu G, Addis EA, US-Venezuela Collaborative Research Group, Cardon LR, Housman DE, Wexler NS (2007) Replication of twelve association studies for Huntington's disease residual age of onset in large Venezuelan kindreds. J Med Genet 44:44–50CrossRefPubMed
4.
go back to reference Weydt P, Soyal SM, Gellera C, Didonato S, Weidinger C, Oberkofler H, Landwehrmeyer GB, Patsch W (2009) The gene coding for PGC-1alpha modifies age at onset in Huntington's disease. Mol Neurodegener 4:3CrossRefPubMed Weydt P, Soyal SM, Gellera C, Didonato S, Weidinger C, Oberkofler H, Landwehrmeyer GB, Patsch W (2009) The gene coding for PGC-1alpha modifies age at onset in Huntington's disease. Mol Neurodegener 4:3CrossRefPubMed
5.
go back to reference Taherzadeh-Fard E, Saft C, Andrich J, Wieczorek S, Arning L (2009) PGC-1alpha as modifier of onset age in Huntington disease. Mol Neurodegener 4:10CrossRefPubMed Taherzadeh-Fard E, Saft C, Andrich J, Wieczorek S, Arning L (2009) PGC-1alpha as modifier of onset age in Huntington disease. Mol Neurodegener 4:10CrossRefPubMed
6.
go back to reference Dhaenens CM, Burnouf S, Simonin C, Van Brussel E, Duhamel A, Defebvre L, Duru C, Vuillaume I, Cazeneuve C, Charles P, Maison P, Debruxelles S, Verny C, Gervais H, Azulay JP, Tranchant C, Bachoud-Levi AC, Dürr A, Buée L, Krystkowiak P, Sablonnière B, Blum D, Huntington French Speaking Network (2009) A genetic variation in the ADORA2A gene modifies age at onset in Huntington's disease. Neurobiol Dis 35:474–476CrossRefPubMed Dhaenens CM, Burnouf S, Simonin C, Van Brussel E, Duhamel A, Defebvre L, Duru C, Vuillaume I, Cazeneuve C, Charles P, Maison P, Debruxelles S, Verny C, Gervais H, Azulay JP, Tranchant C, Bachoud-Levi AC, Dürr A, Buée L, Krystkowiak P, Sablonnière B, Blum D, Huntington French Speaking Network (2009) A genetic variation in the ADORA2A gene modifies age at onset in Huntington's disease. Neurobiol Dis 35:474–476CrossRefPubMed
7.
go back to reference Metzger S, Rong J, Nguyen HP, Cape A, Tomiuk J, Soehn AS, Propping P, Freudenberg-Hua Y, Freudenberg J, Tong L, Li SH, Li XJ, Riess O (2008) Huntingtin- associated protein-1 is a modifier of the age-at-onset of Huntington's disease. Hum Mol Genet 17:1137–1146CrossRefPubMed Metzger S, Rong J, Nguyen HP, Cape A, Tomiuk J, Soehn AS, Propping P, Freudenberg-Hua Y, Freudenberg J, Tong L, Li SH, Li XJ, Riess O (2008) Huntingtin- associated protein-1 is a modifier of the age-at-onset of Huntington's disease. Hum Mol Genet 17:1137–1146CrossRefPubMed
8.
9.
go back to reference Li XJ, Li SH, Sharp AH, Nucifora FC Jr, Schilling G, Lanahan A, Worley P, Snyder SH, Ross CA (1995) A huntingtin-associated protein enriched in brain with implications for pathology. Nature 378:398–402CrossRefPubMed Li XJ, Li SH, Sharp AH, Nucifora FC Jr, Schilling G, Lanahan A, Worley P, Snyder SH, Ross CA (1995) A huntingtin-associated protein enriched in brain with implications for pathology. Nature 378:398–402CrossRefPubMed
10.
11.
go back to reference Li SH, Hosseini SH, Gutekunst CA, Hersch SM, Ferrante RJ, Li XJ (1998) A human HAP1 homologue. Cloning, expression, and interaction with huntingtin. J Biol Chem 273:19220–19227CrossRefPubMed Li SH, Hosseini SH, Gutekunst CA, Hersch SM, Ferrante RJ, Li XJ (1998) A human HAP1 homologue. Cloning, expression, and interaction with huntingtin. J Biol Chem 273:19220–19227CrossRefPubMed
12.
go back to reference Wu LL, Fan Y, Li S, Li XJ, Zhou XF (2010) Huntingtin-associated protein-1 interacts with pro-brain-derived neurotrophic factor and mediates its transport and release. J Biol Chem 285:5614–5623CrossRefPubMed Wu LL, Fan Y, Li S, Li XJ, Zhou XF (2010) Huntingtin-associated protein-1 interacts with pro-brain-derived neurotrophic factor and mediates its transport and release. J Biol Chem 285:5614–5623CrossRefPubMed
13.
go back to reference Kovtun IV, Liu Y, Bjoras M, Klungland A, Wilson SH, McMurray CT (2007) OGG1 initiates age-dependent CAG trinucleotide expansion in somatic cells. Nature 447:447–452CrossRefPubMed Kovtun IV, Liu Y, Bjoras M, Klungland A, Wilson SH, McMurray CT (2007) OGG1 initiates age-dependent CAG trinucleotide expansion in somatic cells. Nature 447:447–452CrossRefPubMed
14.
go back to reference Boiteux S, Radicella JP (2000) The human OGG1 gene: structure, functions, and its implication in the process of carcinogenesis. Arch Biochem Biophys 377:1–8CrossRefPubMed Boiteux S, Radicella JP (2000) The human OGG1 gene: structure, functions, and its implication in the process of carcinogenesis. Arch Biochem Biophys 377:1–8CrossRefPubMed
15.
go back to reference Chen SK, Hsieh WA, Tsai MH, Chen CC, Hong AI, Wei YH, Chang WP (2003) Age-associated decrease of oxidative repair enzymes human 8-oxoguanine DNA glycosylases (OGG1), in human aging. J Radiat Res (Tokyo) 44:31–35CrossRef Chen SK, Hsieh WA, Tsai MH, Chen CC, Hong AI, Wei YH, Chang WP (2003) Age-associated decrease of oxidative repair enzymes human 8-oxoguanine DNA glycosylases (OGG1), in human aging. J Radiat Res (Tokyo) 44:31–35CrossRef
16.
go back to reference Janssen K, Schlink K, Götte W, Hippler B, Kaina B, Oesch F (2001) DNA repair activity of 8-oxoguanine DNA glycosylase 1 (OGG1) in human lymphocytes is not dependent on genetic polymorphism Ser326/Cys326. Mutat Res 486:207–216PubMed Janssen K, Schlink K, Götte W, Hippler B, Kaina B, Oesch F (2001) DNA repair activity of 8-oxoguanine DNA glycosylase 1 (OGG1) in human lymphocytes is not dependent on genetic polymorphism Ser326/Cys326. Mutat Res 486:207–216PubMed
17.
go back to reference Lee AJ, Hodges NJ, Chipman JK (2005) Interindividual variability in response to sodium dichromate-induced oxidative DNA damage: role of the Ser326Cys polymorphism in the DNA-repair protein of 8-oxo-7, 8-dihydro-2′-deoxyguanosine DNA glycosylase 1. Cancer Epidemiol Biomark Prev 14:497–505CrossRef Lee AJ, Hodges NJ, Chipman JK (2005) Interindividual variability in response to sodium dichromate-induced oxidative DNA damage: role of the Ser326Cys polymorphism in the DNA-repair protein of 8-oxo-7, 8-dihydro-2′-deoxyguanosine DNA glycosylase 1. Cancer Epidemiol Biomark Prev 14:497–505CrossRef
18.
go back to reference Bravard A, Vacher M, Moritz E, Vaslin L, Hall J, Epe B, Radicella JP (2009) Oxidation status of human OGG1-S326C polymorphic variant determines cellular DNA repair capacity. Cancer Res 69:3642–3649CrossRefPubMed Bravard A, Vacher M, Moritz E, Vaslin L, Hall J, Epe B, Radicella JP (2009) Oxidation status of human OGG1-S326C polymorphic variant determines cellular DNA repair capacity. Cancer Res 69:3642–3649CrossRefPubMed
19.
go back to reference Gabriel SB, Schaffner SF, Nguyen H, Moore JM, Roy J, Blumenstiel B, Higgins J, DeFelice M, Lochner A, Faggart M, Liu-Cordero SN, Rotimi C, Adeyemo A, Cooper R, Ward R, Lander ES, Daly MJ, Altshuler D (2002) The structure of haplotype blocks in the human genome. Science 296:2225–2229CrossRefPubMed Gabriel SB, Schaffner SF, Nguyen H, Moore JM, Roy J, Blumenstiel B, Higgins J, DeFelice M, Lochner A, Faggart M, Liu-Cordero SN, Rotimi C, Adeyemo A, Cooper R, Ward R, Lander ES, Daly MJ, Altshuler D (2002) The structure of haplotype blocks in the human genome. Science 296:2225–2229CrossRefPubMed
20.
go back to reference Childs E, Hohoff C, Deckert J, Xu K, Badner J, de Wit H (2008) Association between ADORA2A and DRD2 polymorphisms and caffeine-induced anxiety. Neuropsychopharmacology 33:2791–2800CrossRefPubMed Childs E, Hohoff C, Deckert J, Xu K, Badner J, de Wit H (2008) Association between ADORA2A and DRD2 polymorphisms and caffeine-induced anxiety. Neuropsychopharmacology 33:2791–2800CrossRefPubMed
21.
go back to reference Mai M, Akkad AD, Wieczorek S, Saft C, Andrich J, Kraus PH, Epplen JT, Arning L (2006) No association between polymorphisms in the BDNF gene and age at onset in Huntington disease. BMC Med Genet 7:79CrossRefPubMed Mai M, Akkad AD, Wieczorek S, Saft C, Andrich J, Kraus PH, Epplen JT, Arning L (2006) No association between polymorphisms in the BDNF gene and age at onset in Huntington disease. BMC Med Genet 7:79CrossRefPubMed
Metadata
Title
Age at onset in Huntington’s disease: replication study on the associations of ADORA2A, HAP1 and OGG1
Authors
Elahe Taherzadeh-Fard
Carsten Saft
Stefan Wieczorek
Jörg T. Epplen
Larissa Arning
Publication date
01-10-2010
Publisher
Springer-Verlag
Published in
Neurogenetics / Issue 4/2010
Print ISSN: 1364-6745
Electronic ISSN: 1364-6753
DOI
https://doi.org/10.1007/s10048-010-0248-3

Other articles of this Issue 4/2010

neurogenetics 4/2010 Go to the issue